Skip to main content
PLOS One logoLink to PLOS One
. 2017 Jun 1;12(6):e0179139. doi: 10.1371/journal.pone.0179139

Correction: High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients

The PLOS ONE Staff
PMCID: PMC5453612  PMID: 28570697

The affiliation for the last author is incorrect. Takanori Shibata is not affiliated with #6 but with #2 Showa University, School of Medicine, Division of Nephrology, Department of Medicine, Tokyo, Japan. The publisher apologizes for the error.

Reference

  • 1.Honda H, Michihata T, Shishido K, Takahashi K, Takahashi G, Hosaka N, et al. (2017) High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients. PLoS ONE 12(5): e0176984 doi:10.1371/journal.pone.0176984 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES